Site-specific polymer modification of therapeutic proteins

Current Opinion in Chemical Biology

Volumn 9, Issue 6, 2005, Pages 555-560

  Kochendoerfer, Gerd G ^a,b  

^a Gryphon Therapeutics   (United States)

^b FIBROGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANTES; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT PROTEIN;

ALKYLATION; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CHEMICAL BOND; CYCLOADDITION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG INDUSTRY; DRUG SPECIFICITY; ERYTHROPOIESIS; MOLECULAR WEIGHT; POLYMER PRODUCTION; PROTEIN AGGREGATION; PROTEIN ENGINEERING; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SITE DIRECTED MUTAGENESIS; STAUDINGER REACTION; STOP CODON;

DRUG DESIGN; LIGANDS; POLYETHYLENE GLYCOLS; POLYMERS; PROTEIN ENGINEERING; PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 27744530542     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2005.10.007     Document Type: Review

References (59)

1. A.K. Pavlou, and J.M. Reichert Recombinant protein therapeutics- success rates, market trends and values to 2010 Nat Biotechnol 22 2004 1513 1519
2. G.G. Kochendoerfer Chemical and biological properties of polymer-modified proteins Expert Opin Biol Ther 3 2003 1253 1261
3. J.M. Harris, and R.B. Chess Effect of pegylation on pharmaceuticals Nat Rev Drug Discov 2 2003 214 221 Excellent review of protein PEGylation, and its clinical application. The structure and development paths of major approved polymer-modified proteins are discussed.
4. R. Duncan The Dawning era of polymer therapeutics Nat Rev Drug Discov 2 2003 347 360 Excellent review of the application of polymers to drug delivery.
5. M.J. Knauf, D.P. Bell, P. Hirtzer, Z.P. Luo, J.D. Young, and N.V. Katre Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers J Biol Chem 263 1988 15064 15070
6. R. Mehvar Modulation of the pharmacokinetics and pharmacodynamics of proteins by polyethylene glycol conjugation J Pharm Pharm Sci 3 2000 125 136
7. C. Delgado, G.E. Francis, and D. Fisher The uses and properties of PEG-linked proteins Crit Rev Ther Drug Carrier Syst 9 1992 249 304
8. A. Abuchowski, T. Van Es, N.C. Palczuk, and F.F. Davis Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol J Biol Chem 252 1977 3578 3581
9. N.V. Katre Immunogenicity of recombinant IL-2 modified by covalent attachment of polyethylene glycol J Immunol 144 1990 209 213
10. M.L. Nucci, R. Shorr, and A. Abuchowski The therapeutic value of polyethylene glycol-modified proteins Adv Drug Deliv Rev 6 1991 133 151
11. N.V. Katre, M.J. Knauf, and W.J. Laird Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model Proc Natl Acad Sci USA 84 1987 1487 1491
12. P. Bailon, A. Palleroni, C.A. Schaffer, C.L. Spence, W.J. Fung, J.E. Porter, G.K. Ehrlich, W. Pan, Z.X. Xu, and M.W. Modi Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon α-2a for the treatment of hepatitis C Bioconjug Chem 12 2001 195 202
13. M. Yamasaki, M. Asano, M. Okabe, M. Morimoto, and Y. Yokoo Modification of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and its derivative ND 28 with polyethylene glycol J Biochem (Tokyo) 115 1994 814 819
14. Y. Tsutsumi, T. Kihira, S. Yamamoto, K. Kubo, S. Nakagawa, M. Miyake, Y. Horisawa, T. Kanamori, H. Ikegami, and T. Mayumi Chemical modification of natural human tumor necrosis factor-alpha with polyethylene glycol increases its anti-tumor potency Jpn J Cancer Res 85 1994 9 12
15. R. Clark, K. Olson, G. Fuh, M. Marian, D. Mortensen, G. Teshima, S. Chang, H. Chu, V. Mukku, and E. Canova_Davis Long-acting growth hormones produced by conjugation with polyethylene glycol J Biol Chem 271 1996 21969 21977
16. J. Wilken, and S.B.H. Kent Chemical protein synthesis Curr Opin Biotechnol 9 1998 412 426 Excellent review of the history of chemoselective ligation approaches.
17. G.G. Kochendoerfer, and S.B.H. Kent Chemical protein synthesis Curr Opin Chem Biol 3 1999 665 671
18. P.E. Dawson, and S.B.H. Kent Synthesis of native proteins by chemical ligation Annu Rev Biochem 69 2000 923 962
19. Z. Zhang, J. Gildersleeve, Y-Y. Yang, R. Xu, J.A. Loo, S. Uryu, C-H. Wong, and P.G. Schultz A new strategy for the synthesis of glycoproteins Science 303 2004 371 373 Site-specific incorporation of glyco-amino acid building blocks into recombinant proteins in E. coli.
20. J.W. Chin, T.A. Cropp, J.C. Anderson, M. Mukherji, Z. Zhang, and P.G. Schultz An expanded eukaryotic genetic code Science 301 2003 964 967
21. A.J. Link, M.L. Mock, and D.A. Tirrell Non-canonical amino acids in protein engineering Curr Opin Biotechnol 14 2003 603 609
22. V. Goffin, and P. Touraine Pegvisomant (Pharmacia) Curr Opin Investig Drugs 73 2002 752 757
23. Y. Yamamoto, Y. Tsutsumi, Y. Yoshioka, T. Nishibata, K. Kobayashi, T. Okamoto, Y. Mukai, T. Shimizu, S. Nakagawa, and S. Nagata Site-specific PEGylation of a lysine-deficient TNF-α with full bioactivity Nat Biotechnol 21 2003 546 552
24. M.S. Rosendahl, D.H. Doherty, D.J. Smith, S.J. Carlson, E.A. Chlipala, and G.N. Cox A long-acting, highly potent interferon α-2 conjugate created using site-specific PEGylation Bioconjug Chem 16 2005 200 207
25. O.B. Kinstler, D.N. Brems, S.L. Lauren, A.G. Paige, J.B. Hamburger, and M.J. Treuheit Characterization and stability of N-terminally PEGylated rhG-CSF Pharm Res 13 1996 996 1002
26. G. Morstyn, M.A. Foote, T. Walker, and G. Molineux Filgrastim (r-metHuG-CSF) in the 21st century: SD/01 Acta Haematol 105 2001 151 155
27. K. Rose Facile synthesis of homogeneous artificial proteins J Am Chem Soc 116 1994 30 33
28. G.G. Kochendoerfer, J.M. Tack, and S. Cressman Total chemical synthesis of a 27 kDa TASP protein derived from the MscL ion channel of M. tuberculosis by ketoxime-forming ligation Bioconjug Chem 13 2002 474 480
29. H.F. Gaertner, and R.E. Offord Site-specific attachment of functionalized poly(ethylene glycol) to the amino terminus of proteins Bioconjug Chem 7 1996 38 44
30. H.F. Gaertner, K. Rose, R. Cotton, D. Timms, R. Camble, and R.E. Offord Construction of protein analogs by site-specific condensation of unprotected fragments Bioconjug Chem 3 1992 262 268
31. G.G. Kochendoerfer, S.Y. Chen, F. Mao, S. Cressman, S. Traviglia, H. Shao, C.L. Hunter, D.W. Low, E.N. Cagle, and M. Carnevali Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein Science 299 2003 884 887 Total synthesis of a 51 kDa protein-polymer conjugate by purely chemical means. This protein product candidate has entered Phase 1 clinical trials.
32. S.-Y. Chen, S. Cressman, F. Mao, H. Shao, D.W. Low, H.S. Beilan, E.N. Cagle, M. Carnevali, V. Gueriguian, and P.J. Keogh Synthetic erythropoietic proteins: Tuning biological performance by site-specific polymer attachment Chem Biol 12 2005 371 383
33. H. Shao, M.M. Crnogorac, T. Kong, S-Y. Chen, J.M. Williams, J.M. Tack, V. Gueriguian, E.N. Cagle, M. Carnevali, and D. Tumelty Site-specific polymer attachment to a CCL-5 (RANTES) analogue by oxime exchange J Am Chem Soc 127 2005 1350 1351 Polymer attachment to a chemokine modifies aggregation.
34. Saifer MGP, Martinez AL, Williams LD, Sherman MR: Polymer Conjugates of Interferon-beta With Enhanced Biological Potency. PCT Publication WO 2004/0126361.
35. Wei Z, Menon-Rudolph S, Ghosh-Dastidar P: Methods and Kits for Making Polypeptides Having a Single Covalently Bound N-terminal Water-Soluble Polymer. US Patent 2000, 6,077,939.
36. V.W. Cornish, K.M. Hahn, and P.G. Schultz Site-specific protein modification using a ketone handle J Am Chem Soc 118 1996 8150 8151
37. L. Wang, Z. Zhang, A. Brock, and P.G. Schultz Addition of the keto functional group to the genetic code of Escherichia coli Proc Natl Acad Sci USA 100 2003 56 61 Addition of the ketone functionality to proteins in E. coli enables the recombinant production of pharmaceutical proteins for subsequent site-specific polymer attachment.
38. E. Saxon, and C.R. Bertozzi Cell surface engineering by a modified Staudinger reaction Science 287 2000 2007 2010
39. B.L. Nilsson, L.L. Kiessling, and R.T. Raines Staudinger ligation: a peptide from a thioester and azide Org Lett 2 2000 1939 1941
40. E. Saxon, J.I. Armstrong, and C.R. Bertozzi A "traceless" Staudinger ligation for the chemoselective synthesis of amide bonds Org Lett 2 2000 2141 2143
41. C.S. Cazalis, C.A. Haller, L. Sease-Cargo, and E.L. Chaikof C-terminal site-specific PEGylation of a truncated thrombomodulin mutant with retention of full bioactivity Bioconjug Chem 15 2004 1005 1009
42. Q. Wang, T.R. Chan, R. Hilgraf, V.V. Fokin, K.B. Sharpless, and M.G. Finn Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition J Am Chem Soc 125 2003 3192 3193
43. A. Deiters, T.A. Cropp, D. Summerer, M. Mukherji, and P.G. Schultz Site-specific PEGylation of proteins containing unnatural amino acids Bioorg Med Chem Lett 14 2004 5743 5745 Site-specific PEG attachment to a recombinant protein via a specific linkage.
44. P.E. Dawson, T.W. Muir, I. Clark-Lewis, and S.B.H. Kent Synthesis of proteins by native chemical ligation Science 266 1994 776 779
45. P. Botti, M.R. Carrasco, and S.B.H. Kent Native chemical ligation using removable N-α-(1-phenyl-2-mercaptoethyl) auxiliaries Tet Lett 42 2001 1831 1833
46. J. Offer, Boddy CNC, and P.E. Dawson Extending synthetic access to proteins with a removable acyl transfer auxiliary J Am Chem Soc 124 2002 4642 4646
47. L. Yan, and P. Dawson Synthesis of peptides and proteins without cysteine residues by native chemical ligation combined with desulfurization J Am Chem Soc 123 2001 526 533
48. D. Clayton, G. Shapovalov, J.H. Maurer, D.A. Dougherty, H.A. Lester, and G.G. Kochendoerfer Total chemical synthesis and electrophysiological characterization of mechanosensitive channels from Escherichia coli and Mycobacterium tuberculosis Proc Natl Acad Sci USA 101 2004 4764 4769
49. O. Hartley, H. Gaertner, J. Wilken, D. Thompson, R. Fish, A. Ramos, C. Pastore, B. Dufour, F. Cerini, and A. Melotti Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors Proc Natl Acad Sci USA 101 2004 16460 16465
50. I.C. Macdougall, S.J. Gray, O. Elston, C. Breen, B. Jenkins, J. Browne, and J. Egrie Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients J Am Soc Nephrol 10 1999 2392 2395
51. E.C. Rodriguez, L.A. Marcaurelle, and C.R. Bertozzi Aminooxy-, hydrazide-, and thiosemicarbazide-functionalized saccharides: versatile reagents for glycoconjugate synthesis J Org Chem 63 1998 7134 7135
52. L.A. Marcaurelle, E.C. Rodriguez, and C.R. Bertozzi Synthesis of an oxime-linked neoglycopeptide with glycosylation-dependent activity similar to its native counterpart Tet Lett 39 1998 8417 8420
53. L.A. Marcaurelle, and C.R. Bertozzi Chemoselective elaboration of O-linked glycopeptide mimetics by alkylation of 3-thioGalNAc J Am Chem Soc 123 2001 1587 1595
54. H. Liu, L. Wang, A. Brock, C.-H. Wong, and P.G. Schultz A method for the generation of glycoprotein mimetics J Am Chem Soc 125 2003 1702 1703
55. J.D. Warren, J.S. Miller, S.J. Keding, and S.J. Danishefsky Toward fully synthetic glycoproteins by ultimately convergent routes: a solution to a long-standing problem J Am Chem Soc 126 2004 6576 6578
56. Y. Shin, K. Winans, B. Backes, S. Kent, J. Ellman, and C. Bertozzi Fmoc-based synthesis of peptide-αthioesters: application to the total chemical synthesis of a glycoprotein by native chemical ligation J Am Chem Soc 121 1999 11684 11689
57. D. Macmillan, and C.R. Bertozzi Modular assembly of glycoproteins: towards the synthesis of GlyCAM-1 by using expressed protein ligation Angew Chem Int Ed Engl 43 2004 1355 1359
58. D. Macmillan, and L. Arham Cyanogen bromide cleavage generates fragments suitable for expressed protein and glycoprotein ligation J Am Chem Soc 126 2004 9530 9531
59. J. Wilken, D. Hoover, D.A. Thompson, P.N. Barlow, H. McSparron, L. Picard, A. Wlodawer, J. Lubkowski, and S.B.H. Kent Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES Chem Biol 6 1999 43 51